Skip to main content
Close
Home
  • Register or Login
Home

Mary Ellen Schneider

News

Think twice: Choosing Wisely recommendations on testing to avoid in pediatric hematology

Author:
Mary Ellen Schneider
Publish date: December 10, 2019

ORLANDO – The list, which was released by ASH and the American Society of Pediatric Hematology/Oncology, includes five unnecessary tests or...

  • Read More

News

Myeloma patients over age 70 can benefit from auto-HC transplant

Author:
Mary Ellen Schneider
Publish date: December 7, 2019

ORLANDO – Researchers said all myeloma patients should be referred a transplant center, regardless of age.

  • Read More

News

FDA approves treatment for sickle cell pain crises

Author:
Mary Ellen Schneider
Publish date: November 15, 2019

Crizanlizumab-tmca (Adakveo) is approved for patients with sickle cell disease who are aged 16 years and older.

  • Read More

News

FDA approves anemia treatment for transfusion-dependent beta thalassemia patients

Author:
Mary Ellen Schneider
Publish date: November 8, 2019

Luspatercept-aamt (Reblozyl) is approved for adults with beta thalassemia who require regular red blood cell transfusions.

  • Read More

News

ASCO to award $50,000 young investigator grant to study MCL

Author:
Mary Ellen Schneider
Publish date: October 23, 2019

The award is a 1-year grant of $50,000 to pursue clinical research on mantle cell lymphoma.

  • Read More

News

Hematopoietic cell transplant offers realistic cure in secondary AML

Author:
Mary Ellen Schneider
Publish date: October 23, 2019

The observational trial showed that survival was significantly higher with transplant than with chemotherapy consolidation therapy in patients...

  • Read More

News

FDA gives nod to earlier use of Nplate in adults with ITP

Author:
Mary Ellen Schneider
Publish date: October 18, 2019

The drug is now indicated for newly diagnosed and persistent adult patients with immune thrombocytopenia and an insufficient response to other...

  • Read More

News

Translucent particles found in Hemlibra

Author:
Mary Ellen Schneider
Publish date: October 11, 2019

Genentech says the benefit-risk profile of the hemophilia A product is unchanged, and it will continue to be distributed.

  • Read More

News

Progressive myeloma after induction? Go straight to transplant

Author:
Mary Ellen Schneider
Publish date: September 6, 2019

The study did not find a survival advantage for patients who had salvage therapy to deepen their responses before moving on to transplant.

  • Read More

News

Calquence earns breakthrough designation for CLL monotherapy

Author:
Mary Ellen Schneider
Publish date: August 27, 2019

The Bruton tyrosine kinase inhibitor is already approved for the treatment of adults with mantle cell lymphoma who have received at least one...

  • Read More

News

Low-dose radiation therapy looks effective in hard-to-treat MCL

Author:
Mary Ellen Schneider
Publish date: August 7, 2019

The treatment approach can be used safely with concurrent chemotherapy.

  • Read More

News

ABIM rolls out shorter, tailored MOC exams in oncology

Author:
Mary Ellen Schneider
Publish date: July 23, 2019

The new pathway allows oncologists to choose a focused exam in hematologic malignancies, breast cancer, or general oncology every 2 years,...

  • Read More

Video

Cleveland Clinic targets time to treat in cancer

Author:
Mary Ellen Schneider
Publish date: June 3, 2019

CHICAGO – The Taussig Cancer Institute at the Cleveland Clinic reduced the time to treat for newly diagnosed cancer patients by 33%. Taussig’s...

  • Read More

News

Low intensity bridging may be best path to CAR T in adult ALL

Author:
Mary Ellen Schneider
Publish date: June 1, 2019

CHICAGO – Researchers examined the use of high- and low-intensity chemotherapy bridging for patients waiting for treatment with a CD19-directed...

  • Read More

News

FDA approves PI3K inhibitor alpelisib for breast cancer

Author:
Mary Ellen Schneider
Publish date: May 24, 2019

The PI3K inhibitor is approved for use with fulvestrant for HR-positive, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer in...

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2019 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer and privacy policy.

click me
Menu Menu
  • Register or Login
Menu Close
Register or Login